glp-1 intracranial hypertension Idiopathic and the Challenge of Weight Loss Treatment with GLP-1 receptor agonists

These three neuropeptides act on distinct and complementary targets

In a way, NAD+ can help to revitalize or reinvigorate the cells of your body

Stimulation of melanocytes by an MC1R agonist could theoretically promote progression of pre-existing melanocytic lesions to malignant melanoma

They are generally considered for young people with obesity, which is associated with increased risks of health problems like type 2 diabetes, high blood pressure, and heart disease

High Adherence to GLP-1 Receptor Agonists: 18-Month Outcomes from the First Large Scale Operational Quality Follow-Up of the Yazen Model David Buchebner 1 , Elin Skoglund 2 , Kristofer Rigner 3 , Martin Carlsson 1,4 (PO4.146) 1-3